Literature DB >> 7897130

High prevalence of atrial fibrosis in patients with dilated cardiomyopathy.

K Ohtani1, C Yutani, S Nagata, Y Koretsune, M Hori, T Kamada.   

Abstract

OBJECTIVES: We examined the extent of fibrotic changes in the left atrium of cardiomyopathic human hearts and investigated the relation of mechanical overload caused by left ventricular dysfunction to fibrosis of the left atrium.
BACKGROUND: Left atrial dysfunction in dilated cardiomyopathy may contribute to progression of heart failure. In contrast to fibrosis of the left ventricle, atrial fibrosis has not been extensively studied in cardiomyopathic hearts.
METHODS: The extent of fibrosis in the left atrium and left ventricle was determined by an automatic image analyzer in 38 autopsied hearts obtained from 9 patients who died of noncardiac illness (control group), 16 patients with dilated cardiomyopathy, 6 patients with hypertrophic cardiomyopathy with features mimicking dilated cardiomyopathy and 7 patients with a previous myocardial infarction. Transverse sections were obtained at the upper margins of the foramen ovale and left auricle in the left atrium and the median level of the left ventricle.
RESULTS: There were no significant differences in extent of left atrial dilation, left ventricular dysfunction or duration of illness among the three groups with cardiac disease. Percent area of left atrial fibrosis (mean +/- SD) was significantly greater in the specimens from patients with dilated cardiomyopathy (13.1 +/- 6.1%, p < 0.01) and hypertrophic cardiomyopathy mimicking dilated cardiomyopathy (26.5 +/- 9.5%, p < 0.01) than in those from patients with an old myocardial infarction (3.8 +/- 1.1%). Percent area of left ventricular fibrosis in hearts from patients with dilated cardiomyopathy (12.9 +/- 8.6%) was significantly smaller than that in hearts from patients with hypertrophic cardiomyopathy mimicking dilated cardiomyopathy (35.8 +/- 11.9%, p < 0.01) and a previous myocardial infarction (38.4 +/- 8.0%, p < 0.01). Percent area of atrial fibrosis was significantly correlated with left ventricular ejection fraction in the group with a previous myocardial infarction but not in the other groups.
CONCLUSIONS: There was a high degree of fibrotic change in the left atrium in the groups with dilated cardiomyopathy and hypertrophic cardiomyopathy mimicking dilated cardiomyopathy. Our findings suggest that atrial fibrosis in these patients may not have been related to mechanical overload of the left atrium but to some other, still unknown mechanisms.

Entities:  

Mesh:

Year:  1995        PMID: 7897130     DOI: 10.1016/0735-1097(94)00529-y

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  36 in total

Review 1.  Modulation of left atrial function by ventricular filling impairment.

Authors:  A Rossi; P Zardini; P Marino
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

2.  Autonomic remodeling in the left atrium and pulmonary veins in heart failure: creation of a dynamic substrate for atrial fibrillation.

Authors:  Jason Ng; Roger Villuendas; Ivan Cokic; Jorge E Schliamser; David Gordon; Hemanth Koduri; Brandon Benefield; Julia Simon; S N Prasanna Murthy; Jon W Lomasney; J Andrew Wasserstrom; Jeffrey J Goldberger; Gary L Aistrup; Rishi Arora
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-18

3.  Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).

Authors:  Michael A Rosenberg; Marlena Maziarz; Alex Y Tan; Nicole L Glazer; Susan J Zieman; Jorge R Kizer; Joachim H Ix; Luc Djousse; David S Siscovick; Susan R Heckbert; Kenneth J Mukamal
Journal:  Am Heart J       Date:  2014-02-26       Impact factor: 4.749

4.  Challenges for 'diastology': contributions from Japanese researchers.

Authors:  Takashi Oki; Hirokazu Miyoshi; Yoshifumi Oishi; Yukio Mizuguchi; Arata Iuchi; Hirotsugu Yamada; Satoshi Nakatani
Journal:  J Echocardiogr       Date:  2016-08-18

5.  Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.

Authors:  A Rossi; F L Dini; E Agricola; P Faggiano; G Benfari; P L Temporelli; C Cucco; L Scelsi; C Vassanelli; S Ghio
Journal:  J Echocardiogr       Date:  2018-02-23

6.  Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Authors:  C Fielder Camm; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

7.  Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3.

Authors:  Christos Zivlas; Filippos Triposkiadis; Stelios Psarras; Gregory Giamouzis; Ioannis Skoularigis; Stavros Chryssanthopoulos; Alkistis Kapelouzou; Steve Ramcharitar; Edward Barnes; Evangelos Papasteriadis; Dennis Cokkinos
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-08-22

8.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

Review 9.  Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.

Authors:  Lohit Garg; Manasvi Gupta; Syed Rafay Ali Sabzwari; Sahil Agrawal; Manyoo Agarwal; Talha Nazir; Jeffrey Gordon; Babak Bozorgnia; Matthew W Martinez
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

Review 10.  Electrophysiological remodeling in heart failure.

Authors:  Yanggan Wang; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2010-01-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.